Equities analysts expect Phibro Animal Health Corp (NASDAQ:PAHC) to report earnings of $0.43 per share for the current quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Phibro Animal Health’s earnings. Phibro Animal Health posted earnings of $0.46 per share during the same quarter last year, which would indicate a negative year over year growth rate of 6.5%. The business is scheduled to report its next earnings report after the market closes on Monday, May 6th.
According to Zacks, analysts expect that Phibro Animal Health will report full year earnings of $1.68 per share for the current year, with EPS estimates ranging from $1.66 to $1.70. For the next year, analysts anticipate that the firm will post earnings of $1.77 per share, with EPS estimates ranging from $1.76 to $1.80. Zacks’ EPS averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Phibro Animal Health.
Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, February 6th. The company reported $0.41 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by ($0.02). The company had revenue of $218.20 million during the quarter, compared to analyst estimates of $211.59 million. Phibro Animal Health had a net margin of 8.69% and a return on equity of 36.37%. Phibro Animal Health’s revenue was up 6.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.44 earnings per share.
In other Phibro Animal Health news, VP Daniel M. Bendheim sold 2,500 shares of the firm’s stock in a transaction dated Wednesday, January 16th. The stock was sold at an average price of $32.40, for a total transaction of $81,000.00. Following the sale, the vice president now owns 2,500 shares in the company, valued at $81,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Dean J. Warras sold 21,560 shares of the firm’s stock in a transaction dated Tuesday, January 15th. The shares were sold at an average price of $31.81, for a total value of $685,823.60. Following the sale, the insider now owns 21,560 shares in the company, valued at approximately $685,823.60. The disclosure for this sale can be found here. Insiders have sold 41,450 shares of company stock worth $1,319,822 in the last 90 days. Company insiders own 50.29% of the company’s stock.
Large investors have recently made changes to their positions in the company. Northern Trust Corp grew its stake in shares of Phibro Animal Health by 8.0% during the fourth quarter. Northern Trust Corp now owns 452,913 shares of the company’s stock valued at $14,566,000 after buying an additional 33,656 shares during the last quarter. Vanguard Group Inc grew its stake in shares of Phibro Animal Health by 3.3% during the third quarter. Vanguard Group Inc now owns 2,074,840 shares of the company’s stock valued at $89,011,000 after buying an additional 66,676 shares during the last quarter. New York State Common Retirement Fund grew its stake in shares of Phibro Animal Health by 12.8% during the fourth quarter. New York State Common Retirement Fund now owns 52,379 shares of the company’s stock valued at $1,685,000 after buying an additional 5,947 shares during the last quarter. Confluence Investment Management LLC grew its stake in shares of Phibro Animal Health by 70.3% during the fourth quarter. Confluence Investment Management LLC now owns 113,980 shares of the company’s stock valued at $3,665,000 after buying an additional 47,051 shares during the last quarter. Finally, Rhumbline Advisers grew its stake in shares of Phibro Animal Health by 19.9% during the fourth quarter. Rhumbline Advisers now owns 58,359 shares of the company’s stock valued at $1,877,000 after buying an additional 9,699 shares during the last quarter. 49.97% of the stock is currently owned by hedge funds and other institutional investors.
NASDAQ PAHC traded up $0.03 during midday trading on Wednesday, hitting $33.50. The company had a trading volume of 83,770 shares, compared to its average volume of 139,868. The stock has a market capitalization of $1.35 billion, a PE ratio of 19.25, a P/E/G ratio of 3.60 and a beta of 0.62. The company has a debt-to-equity ratio of 1.52, a current ratio of 3.25 and a quick ratio of 1.83. Phibro Animal Health has a twelve month low of $28.28 and a twelve month high of $54.62.
The company also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Wednesday, March 6th were given a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, March 5th. This represents a $0.48 dividend on an annualized basis and a yield of 1.43%. Phibro Animal Health’s payout ratio is 27.59%.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Further Reading: What is Cost of Goods Sold (COGS)?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.